Comment and opinion
- June 2013
- July 2013
- August 2013
- September 2013
- October 2013
- November 2013
- December 2013
- January 2014
- February 2014
- March 2014
- Want to hire creative risk-takers? Doctoral graduates could be the answer
- Scientist-versus-activist debates mislead the public
- Cohort training keeps UK ahead
- Do today's scientific practices really suppress brilliant breakthroughs?
- Philosophy is dead white – and dead wrong
- Has Big Pharma hijacked the European health research budget?
- Vaccinations: what we do in Britain
- Groundbreaking science is blind to prejudice
- HS2 must be one of many new transport links to benefit regions
- What theatre and science can learn from one another
- Wealth increases obesity odds but education reduces them
- Lots of us get flu, but few show symptoms. Let’s not spread it
- Chattering brain cells hold the key to the language of the mind
- Environmental legal aid slashed when Australia needs it most
- Speed reading apps are great for snippets but not sonnets
- April 2014
- May 2014
- June 2014
- July 2014
- August 2014
- September 2014
- October 2014
- November 2014
- December 2014
- January 2015
- February 2015
- March 2015
- April 2015
- May 2015
- June 2015
- July 2015
Call us: +44 (0)20 7679 9041
The UCL Media Relations team is the university’s central press office.
We connect journalists to expert academics and promote UCL research and teaching throughout the global media.
Has Big Pharma hijacked the European health research budget?
21 March 2014
The European Commission has just launched its new €80 billion 7-year science fund Horizon 2020. Separately, the Commission has been negotiating five joint-technology initiatives cofinanced by a range of industries. However, the source of matching funds within Horizon 2020 has been unclear, says Dr Michael Galsworthy (UCL Joint Research Office) in The Lancet.